How should I prepare a calcium gluconate intravenous infusion for an adult requiring rapid calcium replacement (e.g., symptomatic hypocalcemia, hyperkalemia, calcium‑channel‑blocker toxicity)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Prepare a Calcium Gluconate Intravenous Infusion

For adult patients requiring rapid calcium replacement, dilute 10 vials (100 mL) of 10% calcium gluconate in 1 liter of normal saline or 5% dextrose and infuse at 50–100 mL/hour via a secure intravenous line with continuous ECG monitoring. 1

Preparation and Dilution

Standard Concentration

  • Each 10 mL vial of 10% calcium gluconate contains 2.2 mmol (or 9.3 mg/mL) of elemental calcium. 2, 1
  • For continuous infusion, dilute 100 mL of 10% calcium gluconate (10 vials) in 1 liter of normal saline or 5% dextrose. 1
  • This creates a maintenance infusion that delivers approximately 1.1–2.2 mmol of calcium per hour when infused at 50–100 mL/hour. 1

Critical Incompatibilities

  • Never mix calcium gluconate with phosphate-containing fluids or sodium bicarbonate—precipitation will occur immediately. 3, 2
  • Do not administer through the same IV line as sodium bicarbonate or vasoactive amines (epinephrine, dopamine, norepinephrine). 3, 2

Initial Bolus Dosing by Clinical Scenario

Symptomatic Hypocalcemia (Tetany, Seizures, Severe Symptoms)

  • Administer 10–20 mL of 10% calcium gluconate diluted in 50–100 mL of 5% dextrose or normal saline, infused over 10 minutes with continuous ECG monitoring. 1
  • For adults, the dose range is 1–2 grams (10–20 mL of 10% solution) given slowly. 3
  • This bolus can be repeated every 10–20 minutes until symptoms resolve. 1

Calcium Channel Blocker Toxicity

  • Give 30–60 mL (3–6 grams) of 10% calcium gluconate IV every 10–20 minutes, or initiate a continuous infusion at 0.6–1.2 mL/kg/hour (0.06–0.12 g/kg/hour). 4, 3
  • Calcium gluconate is preferred over calcium chloride to minimize peripheral vein irritation in this setting. 4, 3

Hyperkalemia with Cardiac Manifestations

  • Administer 10 mL of 10% calcium gluconate IV over 2–10 minutes with continuous ECG monitoring for membrane stabilization. 3, 5
  • This dose provides cardioprotection but does not lower serum potassium; it must be followed by potassium-lowering therapies. 5

Life-Threatening Arrhythmias or Cardiac Arrest

  • In cardiac arrest, calcium chloride (10 mL of 10% solution) is preferred over calcium gluconate because it raises ionized calcium more rapidly. 6, 5
  • If only calcium gluconate is available, give 30 mL of 10% calcium gluconate (equivalent to 10 mL of 10% calcium chloride). 1

Vascular Access and Administration Route

Preferred Access

  • Central venous access is strongly preferred to prevent extravasation injury, which can cause severe tissue necrosis, calcinosis cutis, and bullous skin reactions. 3, 6, 7
  • If only peripheral access is available, calcium gluconate is safer than calcium chloride (which is highly caustic), but the line must be secure and closely monitored. 3, 6

Extravasation Risk

  • Calcinosis cutis can occur with or without extravasation; if extravasation is suspected or bullous lesions appear, immediately stop the infusion and treat the site. 2, 7
  • Tissue necrosis, ulceration, and secondary infection are the most serious complications of extravasation. 2

Continuous Infusion Protocol

Maintenance Infusion Rate

  • After the initial bolus, start a continuous infusion at 50–100 mL/hour of the diluted solution (100 mL of 10% calcium gluconate in 1 liter of fluid). 1
  • For calcium channel blocker toxicity, the infusion rate is 0.6–1.2 mL/kg/hour of 10% calcium gluconate. 4, 3
  • For post-parathyroidectomy patients, initiate at 1–2 mg elemental calcium per kg per hour and titrate to maintain ionized calcium in the normal range (1.15–1.36 mmol/L). 3

Monitoring During Infusion

  • Measure ionized calcium every 1–4 hours during continuous infusion and every 4–6 hours during intermittent boluses. 3, 2
  • Avoid severe hypercalcemia (ionized calcium greater than twice the upper limit of normal). 6
  • Continuous ECG monitoring is mandatory to detect bradycardia, arrhythmias, or QT changes. 3, 6, 2

Critical Safety Precautions

Cardiac Monitoring and Rate Control

  • Stop the infusion immediately if heart rate decreases by 10 beats per minute or symptomatic bradycardia occurs. 3, 6
  • Even "slow push" administration (over 5–10 minutes) carries arrhythmia risk and requires careful rate control. 3

Digoxin Interaction

  • Avoid calcium administration in patients on digoxin whenever possible; if absolutely necessary, give slowly in small amounts with close ECG monitoring to prevent life-threatening arrhythmias. 3, 2
  • Calcium and cardiac glycosides together can cause synergistic arrhythmias. 2

Hyperphosphatemia Caution

  • When serum phosphate is elevated, exercise extreme caution: additional calcium increases the risk of calcium-phosphate precipitation in tissues, causing obstructive uropathy. 3
  • Consider renal consultation before aggressive calcium replacement in this setting. 3

Special Populations

Renal Impairment

  • Initiate at the lower limit of the dosage range and monitor serum calcium levels every 4 hours. 2

Elderly Patients

  • Start at the low end of the dosage range due to increased risk of adverse effects. 2

Neonates

  • Calcium gluconate is contraindicated in neonates (≤28 days) receiving ceftriaxone due to risk of fatal intravascular precipitates. 2

Common Pitfalls to Avoid

  • Do not treat asymptomatic hypocalcemia—even in tumor lysis syndrome, no calcium replacement is indicated. 3
  • Do not administer calcium rapidly without dilution—this causes hypotension, bradycardia, and cardiac arrest. 2
  • Do not use peripheral access for calcium chloride—it is too caustic and will cause severe tissue injury. 6, 1
  • Do not mix calcium with bicarbonate or phosphate solutions—immediate precipitation occurs. 3, 2

References

Guideline

Calcium Gluconate Dosing for Mild Hypocalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Controversies in Management of Hyperkalemia.

The Journal of emergency medicine, 2018

Guideline

Calcium Gluconate Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bullous skin reaction seen after extravasation of calcium gluconate.

Clinical and experimental dermatology, 2013

Related Questions

What is the immediate intervention for a 73-year-old male with hyperkalemia (elevated potassium levels), peak T waves, and unstable angina (UA) formations on electrocardiogram (EKG)?
What is the proper dilution of 10 milliliters (mml) of calcium gluconate for administration in hyperkalemia?
What is the recommended initial dose of calcium gluconate for hemodialysis patients with hyperkalemia?
What is the recommended dose of calcium gluconate (Ca gluconate) for a patient with severe hyperkalemia and cardiac symptoms?
What are the measures to treat hyperkalemia (elevated potassium levels)?
How should I evaluate and manage a patient with persistent symptomatic hypotension?
What are the age‑specific dosing recommendations and contraindications for the liquid guaifenesin‑dextromethorphan preparation containing 10 mg guaifenesin and 100 mg dextromethorphan per 5 mL?
What are the common side effects of Wellbutrin (bupropion) 150 mg extended‑release?
What are the recommended dosing, administration, and contraindications for guaifenesin‑dextromethorphan oral solution (100 mg guaifenesin/10 mg dextromethorphan per 5 mL) in children aged 4 years and older and in adults?
How should I start hormone replacement therapy in a perimenopausal woman who is still menstruating and has an intact uterus?
How should isolated hypothyroxinemia (low free thyroxine with normal thyroid‑stimulating hormone) in pregnancy be managed, including confirmation, thyroid peroxidase antibody testing, and levothyroxine therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.